Mannose-containing glycoprotein on enveloped virus

Mannose-containing glycoproteins on enveloped viruses refer to **viral surface proteins that are post-translationally modified by the addition of N-linked or O-linked glycans rich in mannose residues**. These modifications occur as the virus hijacks the host cell's secretory pathway during replication. The resulting "high-mannose" structures are often densely clustered—forming so-called "mannose patches"—and serve several critical roles: > - They facilitate **virus attachment and entry** by interacting with specific lectin receptors such as DC-SIGN on dendritic cells; this is well-documented in viruses like HIV and dengue[2][3]. > - The dense array of mannose-rich glycans forms a **protective shield**, masking underlying peptide epitopes from recognition by most antibodies—a phenomenon known as the "glycan shield"[4][5]. > - Despite this shielding effect, certain broadly neutralizing antibodies can specifically recognize these oligomannosylated regions; these have become important leads for vaccine design against pathogens like HIV[5]. The presence and patterning of these mannoses can vary depending on both the virus species/strain and its production environment but tend to be conserved features among many pathogenic enveloped viruses. Their unique structure makes them attractive targets for therapeutic intervention but also presents challenges due to their partial mimicry of host cell-surface carbohydrates. In summary, **mannose-containing glycoproteins are key determinants in viral infectivity, immune evasion, and represent validated targets for antiviral antibody therapies**, especially where they form distinct structural motifs not commonly found in healthy human tissues.[1][2][3][4]

Other names

High-mannose glycan on viral envelope proteinOligomannose patch (context-dependent, e.g., HIV)Viral envelope glycoprotein mannose epitopeMannosylated viral surface protein

Antibodies bind to clustered high-mannose glycans on the viral envelope, blocking receptor interaction or mediating immune clearance